I am getting a lot of questions about Invizyne, and that is very nice thank you, BUT as we just filed for IPO at Nasdaq I am only allowed to share what is in the SEC S1 application: https://lnkd.in/dWnMq3t6 Make sure to read the S1 form in its entirety, including all the valid disclaimers and risk factors, but when you have done that I think you will find the "Business Overview" page 34 very interesting and insightful in regards to the questions about what Invizyne is up to...
Michael Heltzen’s Post
More Relevant Posts
-
There's only one week until Inpart's exclusive webinar with DealForma CEO Chris Dokomajilar. Join us to review the 2023 year in life science partnering - the trends, the ups and downs, the rebounding M&A market, and are there hints of an IPO reboot, too? Reserve your seat today and don't miss out on all the data about all the deals, including those dropping this week at JPM. https://lnkd.in/ggvjA9qy #biopharmapartnering #openinnovation
-
-
📶 Northern Arc Capital IPO Closes with 60% GMP. 🔺 The Northern Arc Capital IPO has concluded successfully, indicating strong investor interest. 🔺 The GMP, a measure of investor anticipation, has surged by 60%, suggesting positive market sentiment towards the company. 🔺 The high GMP suggests that the IPO might have been oversubscribed, meaning demand for shares exceeded the supply. 🔺 The strong response to the IPO reflects investor confidence in Northern Arc Capital's business model, financial prospects, and growth potential. 🔺 The high GMP suggests that investors are optimistic about Northern Arc Capital's future performance and believe that the shares are likely to be priced at a premium on listing. #newsanalysis Rishabh Kale
-
-
Kronox Lab Sciences IPO Listed at Premium of 21.29% at ₹164.95/share vs issue price of ₹136/share . . #kronoxlab #ipoallotment #iponews #ipoalert #stocks #shares #stockmarket #sharemarketindia #stockmarketindia #sharemarket #stockmarketinvesting #directusinvestments
-
Manager, Tax Recovery @ Ryan | Expertise in VAT & keen interest in tech innovation & private equity
IPOs raised big bucks in the first quarter of 2024, with seven deals raising more than $500 million each. Here are the opportunities and challenges: ↓↓↓ ➡️ Opportunities Tech and AI Boom → Companies like Reddit, Inc., Astera Labs, and Kyverna Therapeutics are leading the charge, showcasing innovation and strong market debuts. Improved Valuations → Growing confidence among investors is leading to better pricing levels, making it a favorable time for high-profile IPOs. ➡️ Challenges Market Volatility → Ongoing economic uncertainties and fluctuating interest rates continue to pose risks. Geopolitical Tensions → Issues like Middle East conflicts and Russia/Ukraine add to market instability, impacting investor sentiment. However, the outlook for Q2 of 2024 remains optimistic, with a bunch of companies preparing to go public. Follow for more updates! #ipo #ipos #recentipos #ipomarket
-
Kronox Lab Sciences IPO Listed at Premium of 21.29% at ₹164.95/share vs issue price of ₹136/share . . #kronoxlab #ipoallotment #iponews #ipoalert #stocks #shares #stockmarket #sharemarketindia #stockmarketindia #sharemarket #stockmarketinvesting #directusinvestments
-
ICYMI: Mid-Caps at the Center of Attention – Mid-cap companies tend to be more established than small caps and offer more longer-term upside potential than large caps. So, why are they under-owned by investors? Learn why #midcaps deserve more attention in this paper featuring insights from Virtus affiliate Kayne Anderson Rudnick: https://ow.ly/XeSe30sAbFW
-
-
Head of Defined Contribution and Sub-Advisory @ Virtus Investment Partners | New Business Development, Client Relationship Management | College of Wooster Board of Trustees
ICYMI: Mid-Caps at the Center of Attention – Mid-cap companies tend to be more established than small caps and offer more longer-term upside potential than large caps. So, why are they under-owned by investors? Learn why #midcaps deserve more attention in this paper featuring insights from Virtus affiliate Kayne Anderson Rudnick: https://ow.ly/kLGl30sAiUT
-
-
Kronox Lab Sciences IPO Subscription Status . http://bit.ly/3s1roj7 . #KronoxLabSciences #iporeview #KronoxLabSciencesCornipo #KronoxLabSciencesiporeview #IPOnews #IPOs #IPOAlert #InvestmentOpportunity #TransformingTech #IPOannouncement #IPOFiling #ipo #stockmarket #indianstockmarket #ipoalert #iponews #stockmarket #investing #stocks #shares #stockstotrade #stockmarketindia #directusinvestments
-
-
Quest Laboratories Limited IPO Details . http://bit.ly/3s1roj7 . #Questlaboratories #iporeview #Questlaboratoriesipo #Questlaboratoriesiporeview #IPOnews #IPOs #IPOAlert #InvestmentOpportunity #TransformingTech #IPOannouncement #IPOFiling #ipo #stockmarket #indianstockmarket #ipoalert #iponews #stockmarket #investing #stocks #shares #stockstotrade #stockmarketindia #directusinvestments
-
-
Kronox Lab Sciences IPO Subscription Status . http://bit.ly/3s1roj7 . #KronoxLabSciences #iporeview #KronoxLabSciencesCornipo #KronoxLabSciencesiporeview #IPOnews #IPOs #IPOAlert #InvestmentOpportunity #TransformingTech #IPOannouncement #IPOFiling #ipo #stockmarket #indianstockmarket #ipoalert #iponews #stockmarket #investing #stocks #shares #stockstotrade #stockmarketindia #directusinvestments
-
